Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Enhanced Platform Processes IHC and ISH Patient Samples

By LabMedica International staff writers
Posted on 11 Aug 2011
An enhanced platform enables laboratories to process individual immunohistochemistry (IHC) and in situ hybridization (ISH) samples as soon as they arrive in the lab.

The improvement allows labs to respond quickly to unpredictable changes in workflow, improving test turnaround time and reducing stress associated with day-to-day laboratory changes. More...


The BenchMark ULTRA with new Ultimate Reagent Access (URA) provides a new software and hardware package which gives the operator full workflow control by allowing access to any slide, any reagent, anytime. URA eliminates the need to batch slides, reduces preplanning requirements, and allows late-arriving slides to be run STAT.

URA completes the total system access of ULTRA, increasing overall slide turnaround time because instrument preparation tasks can be managed while slides are processing. Multiparameter testing, such as dual and triple stains, can be performed independent of other slides, allowing for rapid patient results. With URA, labs can manage workflow with random access to 30 individual staining chambers, allowing for real-time STAT processing.

The new BenchMark ULTRA platform together with URA was launched by Ventana Medical Systems, Inc. (Tucson, AZ, USA), a member of the Roche Group (Basel, Switzerland).

Related Links:
Ventana Medical Systems
Roche


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.